Hydroxychloroquine (HCQ) decreases the benefit of anti-PD-1 immune checkpoint blockade in tumor immunotherapy
羟氯喹 (HCQ) 降低了抗 PD-1 免疫检查点阻断在肿瘤免疫治疗中的益处
期刊:PLoS One
影响因子:2.9
doi:10.1371/journal.pone.0251731
Janna Krueger, Francois Santinon, Alexandra Kazanova, Mark E Issa, Bruno Larrivee, Richard Kremer, Catalin Milhalcioiu, Christopher E Rudd